Analyst Research Report Snapshot

Title:

La Jolla Pharmaceutical Company

Price:

$50.00

Provider:

MarketLine (a Datamonitor Company)

Date:

12 Aug 2013

Pages:

27

Type:

AcrobatPDF

Companies referenced:

LJPC.OB

Available for Immediate Download
Summary:

La Jolla Pharmaceutical Company - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on La Jolla Pharmaceutical Company required for business and competitor intelligence needs - Intelligence on La Jolla Pharmaceutical Company’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about La Jolla Pharmaceutical Company, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: La Jolla Pharmaceutical (La Jolla) is a biopharmaceutical company involved in development of treatments that improve outcomes in patients with life-threatening diseases. The company focuses on the science of galectins to develop new therapies to treat human diseases such as cancer and chronic organ failure. The company's lead product, GCS-100, is an inhibitor designed to sequester and eliminate circulating levels of galectin-3. The company primarily operates in the US, where it is headquartered in San Diego, California, and employs around two people. The company did not generate revenues in the fiscal year ended December 2011. The company's operating loss was $2.3 million in fiscal 2011, as compared to an operating loss of $3.9 million in 2010. Its net loss was $11.5 million in fiscal 2011, as compared to the net loss of $3.8 million in 2010. Reasons to Purchase: - Gain understanding of La Jolla Pharmaceutical Company the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess La Jolla Pharmaceutical Company as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on La Jolla Pharmaceutical Company your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.